114 related articles for article (PubMed ID: 2894026)
1. In vivo study of glucose-induced somatostatin secretion: comparison in normal and alloxan-diabetic dogs.
Ribes G; Gross R; Chenon D; Puech R; Loubatieres-Mariani MM
Pancreas; 1987; 2(6):638-44. PubMed ID: 2894026
[TBL] [Abstract][Full Text] [Related]
2. Evidence for a role of free fatty acids in the regulation of somatostatin secretion in normal and alloxan diabetic dogs.
Wasada T; Howard B; Dobbs RE; Unger RH
J Clin Invest; 1980 Sep; 66(3):511-6. PubMed ID: 6105166
[TBL] [Abstract][Full Text] [Related]
3. Effect of insulin on basal pancreaticoduodenal output of somatostatin in normal and diabetic dogs.
Ribes G; Gross R; Chenon D; Loubatières-Mariani MM
Acta Endocrinol (Copenh); 1988 Sep; 119(1):43-50. PubMed ID: 2901182
[TBL] [Abstract][Full Text] [Related]
4. Origin of peripheral venous hypersomatostatinemia in alloxan-diabetic dogs.
Schusdziarra V; Rouiller D; Harris V; Unger RH
Endocrinology; 1981 Oct; 109(4):1107-16. PubMed ID: 6116595
[TBL] [Abstract][Full Text] [Related]
5. In vivo and in vitro effects of adenosine-5'-O-(2-thiodiphosphate) on pancreatic hormones in dogs.
Hillaire-Buys D; Gross R; Parés-Herbuté N; Ribes G; Loubatières-Mariani MM
Pancreas; 1994 Sep; 9(5):646-51. PubMed ID: 7809020
[TBL] [Abstract][Full Text] [Related]
6. Contribution of the pancreas to circulating somatostatin-like immunoreactivity in the normal dog.
Taborsky GJ; Ensinck JW
J Clin Invest; 1984 Jan; 73(1):216-23. PubMed ID: 6140271
[TBL] [Abstract][Full Text] [Related]
7. Insulin inhibits somatostatin-like immunoreactivity release stimulated by intragastric HCl.
Rouiller D; Schusdziarra V; Unger RH
Diabetes; 1981 Sep; 30(9):735-8. PubMed ID: 6114888
[TBL] [Abstract][Full Text] [Related]
8. Effect of 2-deoxy-D-glucose on plasma somatostatin levels in conscious dogs.
Wasada T; Dobbs RE; Harris V; Unger RH
Endocrinology; 1981 Apr; 108(4):1222-7. PubMed ID: 6110537
[TBL] [Abstract][Full Text] [Related]
9. Opposing actions of glucagon and insulin on splanchnic d cell function.
Kawai K; Unger RH
J Clin Invest; 1983 Mar; 71(3):721-5. PubMed ID: 6131079
[TBL] [Abstract][Full Text] [Related]
10. Alterations in somatostatin and other islet cell functions in the spontaneously diabetic BB Wistar rat: biochemical and morphological characterization.
Patel YC; Ruggere D; Malaisse-Lagae F; Orci L
Metabolism; 1983 Jul; 32(7 Suppl 1):18-25. PubMed ID: 6135136
[TBL] [Abstract][Full Text] [Related]
11. Response of plasma somatostatin-like immunoreactivity to the administration of alloxan in dogs.
Schusdziarra V; Harris V; Unger R
Horm Metab Res; 1979 Aug; 11(8):457-9. PubMed ID: 499995
[TBL] [Abstract][Full Text] [Related]
12. [Paradoxical hyperglucagonemia after oral administration of glucose in diabetic dogs. Impact of the cholinergic nervous system].
Hillaire-Buys D; Ribes G; Gross R; Loubatières-Mariani MM
C R Seances Soc Biol Fil; 1987; 181(6):677-82. PubMed ID: 2970286
[TBL] [Abstract][Full Text] [Related]
13. Modulation of motilin-induced somatostatin release in dogs by naloxone.
Schick R; Schusdziarra V
Peptides; 1985; 6(5):861-4. PubMed ID: 2867525
[TBL] [Abstract][Full Text] [Related]
14. [Effects of cysteamine on canine splanchnic D-cells].
Kawai K
Nihon Naibunpi Gakkai Zasshi; 1983 Jul; 59(7):962-72. PubMed ID: 6138285
[TBL] [Abstract][Full Text] [Related]
15. Pancreatic and gastric somatostatin release in response to intragastric and intraduodenal nutrients and HCl in the dog.
Schusdziarra V; Harris V; Conlon JM; Arimura A; Unger R
J Clin Invest; 1978 Sep; 62(3):509-18. PubMed ID: 690183
[TBL] [Abstract][Full Text] [Related]
16. Abnormal D cell secretion in alloxan-diabetes: influence by drug and aberrant metabolism.
Grill V; Efendić S
Am J Physiol; 1984 Jun; 246(6 Pt 1):E483-92. PubMed ID: 6204535
[TBL] [Abstract][Full Text] [Related]
17. Somatostatin secretion in diabetic rabbits.
Wilson HK; Boyd AE; Bolton WE; Conaway HH
Metabolism; 1982 May; 31(5):428-32. PubMed ID: 6123063
[TBL] [Abstract][Full Text] [Related]
18. Paradoxical reduction in pancreatic glucagon with normalization of somatostatin and decrease in insulin in normoglycemic alloxan-diabetic dogs: a putative mechanism of glucagon irresponsiveness to hypoglycemia.
Rastogi KS; Lickley L; Jokay M; Efendic S; Vranic M
Endocrinology; 1990 Feb; 126(2):1096-104. PubMed ID: 1967577
[TBL] [Abstract][Full Text] [Related]
19. A stimulating effect of glucose on somatostatin release is impaired in noninsulin-dependent diabetes mellitus.
Grill V; Gutniak M; Roovete A; Efendić S
J Clin Endocrinol Metab; 1984 Aug; 59(2):293-7. PubMed ID: 6145723
[TBL] [Abstract][Full Text] [Related]
20. Intracerebroventricular administration of somatostatin octapeptide counteracts the hormonal and metabolic responses to stress in normal and diabetic dogs.
Miles PD; Yamatani K; Brown MR; Lickley HL; Vranic M
Metabolism; 1994 Sep; 43(9):1134-43. PubMed ID: 7916119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
